• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坎帕尼亚地区X连锁型进行性肌营养不良的前瞻性研究。

Prospective study of X-linked progressive muscular dystrophy in Campania.

作者信息

Nigro G, Comi L I, Limongelli F M, Giugliano M A, Politano L, Petretta V, Passamano L, Stefanelli S

出版信息

Muscle Nerve. 1983 May;6(4):253-62. doi: 10.1002/mus.880060403.

DOI:10.1002/mus.880060403
PMID:6683357
Abstract

Within the Campania region of southern Italy a prospective study on X-linked progressive muscular dystrophy was conducted over a period of 12 years from 1969 to 1980, inclusive. The mean incidence rate was 21.7 per 100,000 male livebirths for Duchenne muscular dystrophy (DMD) cases and 3.2 per 100,000 male livebirths for Becker muscular dystrophy (BMD) cases. The familial cases were 38.5% among the DMD patients and 50% among the BMD patients. Myocardial involvement appeared in DMD patients at about 6 years of age in a high percentage of cases and increased progressively until the last years of life, when cardiac damage occurred in 95% of cases. The percentage of myocardial involvement in BMD patients was very low before 13 years of age, but increased progressively until 20 years, when cardiac damage occurred in 80% of cases studied; severe cardiomyopathy did not occur before the age of 21. The data reported also include the effects of age on physical performance, serum creatine kinase activity and serum myoglobin levels, the types of cardiac damage, and the causes of death.

摘要

1969年至1980年(含)的12年间,在意大利南部的坎帕尼亚地区开展了一项关于X连锁进行性肌营养不良的前瞻性研究。杜氏肌营养不良(DMD)病例的平均发病率为每10万例男性活产21.7例,贝克肌营养不良(BMD)病例的平均发病率为每10万例男性活产3.2例。DMD患者中的家族性病例占38.5%,BMD患者中的家族性病例占50%。在DMD患者中,约6岁时出现心肌受累的病例比例很高,且逐年递增,直至生命的最后几年,95%的病例出现心脏损害。13岁之前,BMD患者中心肌受累的比例非常低,但逐渐上升,直至20岁,此时所研究病例中的80%出现心脏损害;21岁之前未发生严重心肌病。报告的数据还包括年龄对身体机能、血清肌酸激酶活性和血清肌红蛋白水平的影响、心脏损害类型以及死亡原因。

相似文献

1
Prospective study of X-linked progressive muscular dystrophy in Campania.坎帕尼亚地区X连锁型进行性肌营养不良的前瞻性研究。
Muscle Nerve. 1983 May;6(4):253-62. doi: 10.1002/mus.880060403.
2
Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.杜兴氏/贝克氏肌营养不良女性携带者血液中X染色体失活偏倚与血清肌酸激酶水平之间无相关性。
Am J Med Genet. 1998 Dec 4;80(4):356-61.
3
The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy.贝克尔肌营养不良症、面肩肱型肌营养不良症和贝斯勒姆肌病中的心脏
Muscle Nerve. 1992 May;15(5):591-6. doi: 10.1002/mus.880150510.
4
Serum myoglobin in muscular dystrophy.肌营养不良症中的血清肌红蛋白。
Muscle Nerve. 1980 May-Jun;3(3):221-6. doi: 10.1002/mus.880030306.
5
Becker and Duchenne muscular dystrophy: a comparative morphological study.贝克型和杜兴型肌营养不良症:一项比较形态学研究。
Aust Paediatr J. 1988;24 Suppl 1:15-20.
6
Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.肌营养不良中扩张型心肌病的遗传预测因子与重塑
Circulation. 2005 Nov 1;112(18):2799-804. doi: 10.1161/CIRCULATIONAHA.104.528281. Epub 2005 Oct 24.
7
X;autosome translocations in females with Duchenne or Becker muscular dystrophy.
Nature. 1986;322(6076):291-2. doi: 10.1038/322291b0.
8
Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.X连锁肌营养不良患者亲属的肌酸磷酸激酶(CPK)活性:一项巴西的研究。
J Genet Hum. 1976 Jun;24(2):153-68.
9
Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
Am J Med Genet. 1985 Sep;22(1):81-7. doi: 10.1002/ajmg.1320220109.
10
Cardiorespiratory function in Duchenne and Becker muscular dystrophy.杜氏和贝克型肌营养不良症中的心肺功能。
Turk J Pediatr. 1996 Jul-Sep;38(3):307-14.

引用本文的文献

1
Management of Cardiac Involvement in Becker Muscular Dystrophy: A Case Report.贝克肌营养不良症心脏受累的管理:一例报告
Cureus. 2024 Nov 5;16(11):e73029. doi: 10.7759/cureus.73029. eCollection 2024 Nov.
2
Recent Advances in Pre-Clinical Development of Adiponectin Receptor Agonist Therapies for Duchenne Muscular Dystrophy.用于杜兴氏肌营养不良症的脂联素受体激动剂疗法的临床前开发的最新进展
Biomedicines. 2024 Jun 25;12(7):1407. doi: 10.3390/biomedicines12071407.
3
Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response.
杜氏肌营养不良症中的心肌病和线粒体治疗药物改善治疗反应的潜力。
Cells. 2024 Jul 9;13(14):1168. doi: 10.3390/cells13141168.
4
Duchenne muscular dystrophy in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact.意大利杜氏肌营养不良症:流行病学、生活质量、治疗依从性和经济影响的系统评价。
PLoS One. 2023 Jun 27;18(6):e0287774. doi: 10.1371/journal.pone.0287774. eCollection 2023.
5
The extracellular matrix of dystrophic mouse diaphragm accounts for the majority of its passive stiffness and is resistant to collagenase digestion.营养不良小鼠膈肌的细胞外基质占其被动僵硬度的大部分,并且对胶原酶消化具有抗性。
Matrix Biol Plus. 2023 Mar 13;18:100131. doi: 10.1016/j.mbplus.2023.100131. eCollection 2023 Jun.
6
Giovanni Nigro and the Naples's school: historical contribution to the knowledge of heart involvement in Duchenne/Becker muscular dystrophies.乔瓦尼·尼格鲁和那不勒斯学派:对杜兴氏肌营养不良症/贝克肌营养不良症心脏受累知识的历史贡献。
Acta Myol. 2020 Dec 1;39(4):187-190. doi: 10.36185/2532-1900-021. eCollection 2020 Dec.
7
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.全球杜氏肌营养不良症的流行病学:一项更新的系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8.
8
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.比较杜氏肌营养不良症和贝克肌营养不良症肌肉的蛋白质组学分析:导致贝克肌营养不良症患者肌肉功能得以保留的变化。
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):547-563. doi: 10.1002/jcsm.12527. Epub 2020 Jan 28.
9
The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy.“惯常嫌疑基因”:炎症、纤维化、再生及肌肉力量相关基因对杜氏肌营养不良症产生影响
J Clin Med. 2019 May 10;8(5):649. doi: 10.3390/jcm8050649.
10
Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.血管紧张素转换酶抑制剂与β受体阻滞剂联合治疗预防杜氏肌营养不良症(DMD)患儿心肌病的随机安慰剂对照试验(DMD心脏保护研究):一项方案研究。
BMJ Open. 2018 Dec 19;8(12):e022572. doi: 10.1136/bmjopen-2018-022572.